SRRA
Sierra Oncology, Inc. Common Stock
SRRA
SRRA
Delisted
SRRA was delisted on the 30th of June, 2022.
29 hedge funds and large institutions have $75.2M invested in Sierra Oncology, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
29
Holding in Top 10
1
Calls
$4K
Puts
–
Top Buyers
| 1 | +$282K | |
| 2 | +$255K | |
| 3 | +$162K | |
| 4 |
VF
Virtu Financial
New York
|
+$59K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$8K |
Top Sellers
| 1 | -$1.44M | |
| 2 | -$1.28M | |
| 3 | -$924K | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$781K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$423K |